World's first real-time drug‑device intervention for post‑trauma disorder prevention.
Millions live with post-traumatic stress. Every existing treatment waits for the damage, then manages the symptoms. TraumaShield changes the equation.
They save the life.
Then they lose the person.
A paramedic reaches a car before the fire does. A soldier carries his friend out. A nurse holds a hand through the worst night of someone's life. They are extraordinary at what they do — and they do it again tomorrow.
But months later, the person they saved cannot sleep. Cannot work. Cannot be in a room with the door closed. The body healed. The mind did not.
We are not here to replace the heroes.
We are here to give them one more thing to carry — and one more life to save.
Trauma is inevitable.
PTSD is preventable.
We are building a world where trauma becomes a memory, not a lifelong disorder — a world where post-trauma disorders no longer exist, and where PTSD, depression, anxiety, addiction and phobias are prevented and treated at their core.
Trauma strikes in an instant — and every day, first responders fight to pull people back from the edge. They save lives with extraordinary skill, yet the most devastating wound is the one no one can treat.
TraumaShield is on a mission to lead the world toward a better future — one where the worst moment of a person's life does not become the rest of it.
How it worksAddressing a
therapeutic gap.
Post-traumatic stress disorder is a devastating mental health crisis — yet no approved solution prevents it. Current treatments manage symptoms long after the damage is done.
There is no FDA-approved prevention for the critical "golden hours" post-trauma. That is the gap TraumaShield was built to close.
Before the golden hours close.
In the first six hours after trauma, the brain is still deciding how the memory will be stored. Today's care waits years to treat the scar. TraumaShield acts while it is still a wound.
opportunity
The mental
tourniquet.
A field-ready device pairs with an FDA-approved agent, reaching patients inside the 0-6 hour window to reduce fear-memory consolidation and restore healthy contextual memory before PTSD can form.
A single non-invasive dose, given immediately post-trauma.
Acts on the brain's fear-memory circuits during the consolidation window.
Fear-memory consolidation reduced. Event encoded as history, not nightmare.
Medicine has closed
every window but this one.
Three centuries of medicine is one story told repeatedly: intervene earlier, and the catastrophe never happens. Every step below was impossible until someone did it.
Stop the bleeding at the point of injury, before it becomes fatal. The first true field intervention.
Prevent the disease instead of treating the dying. The idea that changed public health forever.
Act after exposure but before the disease takes hold — the first proof that a closing window can be used.
A window measured in hours becomes an accepted medical category.
Epinephrine was a century old. Putting a known drug into a device anyone could use created a multi-billion-dollar standard of care.
Post-exposure prevention turns a death sentence into a protocol.
A drug developed for angina became a blockbuster through a second medical use — proof the repurposing model works.
Naloxone had sat in hospitals for decades. A nasal format in every first-responder kit turned it into public infrastructure.
230 years after the first vaccine, the most devastating psychiatric injury of our time still has no approved prevention. The window is open. Now it is time to act.
Sometimes world‑changing solutions wait for the moment when science, timing, and perspective finally align — this is that moment, wouldn’t you agree?
We now understand memory consolidation well enough to interrupt it. That was not true a decade ago.
Wars, mass-casualty events and a global mental-health crisis are generating trauma faster than any system can absorb.
Military and emergency medicine proved that treating injury at the point of trauma saves lives. TraumaShield applies the same principle to the mind.
Significant reduction in PTSD incidence.
Independent, peer-reviewed human data show a statistically significant reduction in PTSD incidence, reproduced in preclinical models.
Independent peer-reviewed study · reference available to qualified partners.
The difference is
one intervention.
13 million Americans live with PTSD, and the number grows with every conflict.
$232B a year is spent managing symptoms that were never prevented.
Careers end. Marriages end. Some lives end. Decades of human potential quietly disappear.
First responders keep saving bodies, and keep losing the people inside them.
The right team
for the mission.
A group of people who have already shaped the field they are now setting out to change.
Every mission was impossible until someone solved it. With the right team, it is time to rethink the impossible.
Meet the team
Our latest events.
Rethink the
impossible with us.
If you are aligned with the mission and ready for the challenge, join us.
Stealth · Detailed materials shared under NDA